Advances in Targeted Protein Degradation
Discover Glo Webinar Series
Over the last 30 years, assays and technologies utilizing the natural phenomenon of bioluminescence have gone from novel research tools to foundational elements of the modern research toolbox. Innovation utilizing bioluminescent approaches continues, further expanding both the available methods and the scientific advancements made by life science and drug discovery researchers. In this webinar series you will hear from industry experts and Promega scientists who will share research updates on important research topics included Kinases, GPCRs, and Targeted Protein Degradation. You will also learn about recent technology advancements that can be applied to these as well as other drug targets and research areas.
Session 4 - Advances in Targeted Protein Degradation
Selectively targeting proteins for degradation and removal from the cell is an exciting new therapeutic approach that is expanding our definition of the druggable proteome. This approach involves developing novel small molecules that can modulate protein-protein interactions inside the cell, sending the target protein through the cell’s natural ubiquitin proteasome pathway. In this session two leading experts in the field of targeted protein degradation will present new insights into cellular processes that can be utilized for targeting proteins for degradation and methods and techniques for the assessment of target protein dynamics.
Other webinars in this series:
Dr. Alessio Ciulli
Professor of Chemical and Structural Biology
University of Dundee, School of Life Sciences
Dr. Danette Daniels
Senior Research Scientist and Group Leader, Functional Proteomics